粒细胞集落刺激因子诱导的血小板减少症。
Filgrastim induced thrombocytopenia.
机构信息
George Washington University, Washington, District of Columbia, USA
George Washington University, Washington, District of Columbia, USA.
出版信息
BMJ Case Rep. 2020 Jun 30;13(6):e234584. doi: 10.1136/bcr-2020-234584.
Abstract
Drug-induced thrombocytopenia (DITP) is suggested by severe thrombocytopenia with subsequent recovery of platelet count after removal of the offending drug. The diagnosis is ascertained when there is reproducibility of thrombocytopenia with repeated exposure. Filgrastim is used during peripheral blood progenitor cell harvest during autologous stem cell transplantation in the setting of multiple myeloma to prolong event-free survival and overall mortality. The following case illustrates all of the suggestive features of DITP after filgrastim exposure during elective stem cell harvest. Due to the inability to tolerate filgrastim, autologous stem cell transplant was aborted in this patient and he was maintained on induction chemotherapy.
摘要
药物诱导的血小板减少症（DITP）的特征是严重血小板减少症，随后在停用致病药物后血小板计数恢复。当反复暴露于药物时出现血小板减少症的可重复性时，即可确诊。在多发性骨髓瘤患者的自体干细胞移植中，使用粒细胞集落刺激因子（filgrastim）在外周血造血祖细胞采集期间，以延长无事件生存和总死亡率。以下病例说明了在选择性干细胞采集期间使用粒细胞集落刺激因子（filgrastim）后，所有提示 DITP 的特征。由于不能耐受粒细胞集落刺激因子（filgrastim），该患者的自体干细胞移植被取消，他继续接受诱导化疗。
相似文献
1
Filgrastim induced thrombocytopenia.粒细胞集落刺激因子诱导的血小板减少症。
BMJ Case Rep. 2020 Jun 30;13(6):e234584. doi: 10.1136/bcr-2020-234584.
2
Pegylated Filgrastim Versus Filgrastim for Stem Cell Mobilization in Multiple Myeloma After Novel Agent Induction.聚乙二醇化非格司亭与非格司亭用于新型药物诱导后多发性骨髓瘤干细胞动员的比较
Clin Lymphoma Myeloma Leuk. 2018 Mar;18(3):174-179. doi: 10.1016/j.clml.2017.12.010. Epub 2018 Jan 5.
3
A single-center, retrospective analysis to compare the efficacy and safety of filgrastim-sndz to filgrastim for prophylaxis of chemotherapy-induced neutropenia and for neutrophil recovery following autologous stem cell transplantation.一项单中心、回顾性分析比较了 filgrastim-sndz 与 filgrastim 预防化疗引起的中性粒细胞减少症和自体干细胞移植后中性粒细胞恢复的疗效和安全性。
Support Care Cancer. 2018 Mar;26(3):1013-1016. doi: 10.1007/s00520-017-3923-1. Epub 2017 Oct 8.
4
Filgrastim-alone versus pegylated filgrastim-alone for autologous peripheral blood stem cells mobilization in newly diagnosed multiple myeloma patients.在新诊断的多发性骨髓瘤患者中，单用非格司亭与单用聚乙二醇化非格司亭用于自体外周血干细胞动员的比较。
Wien Klin Wochenschr. 2017 Aug;129(15-16):545-551. doi: 10.1007/s00508-017-1205-z. Epub 2017 Apr 24.
5
[Efficacy and safety of biosimilar filgrastim for autologous peripheral blood stem cell harvest and transplantation: a single-institutional retrospective analysis].生物类似药非格司亭用于自体外周血干细胞采集和移植的疗效及安全性：单机构回顾性分析
Rinsho Ketsueki. 2018;59(2):145-152. doi: 10.11406/rinketsu.59.145.
6
Phase 1 study of pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) in breast cancer patients after autologous peripheral blood progenitor cell (PBPC) transplantation.聚乙二醇化重组人巨核细胞生长与发育因子（PEG-rHuMGDF）在自体外周血祖细胞（PBPC）移植后乳腺癌患者中的1期研究。
Bone Marrow Transplant. 2000 Jul;26(2):141-5. doi: 10.1038/sj.bmt.1702465.
7
Mexican Biosimilar Filgrastim for Autologous Hematopoietic Stem Cell Mobilization and Transplantation.用于自体造血干细胞动员和移植的墨西哥生物类似药非格司亭
Rev Invest Clin. 2016 Jul-Aug;68(4):181-3.
8
Fixed-dose single agent pegfilgrastim for peripheral blood progenitor cell mobilisation in patients with multiple myeloma.固定剂量单药聚乙二醇化重组人粒细胞刺激因子用于多发性骨髓瘤患者外周血祖细胞动员
Br J Haematol. 2006 Jun;133(5):533-7. doi: 10.1111/j.1365-2141.2006.06054.x.
9
Efficacy and cost of G-CSF derivatives for prophylaxis of febrile neutropenia in lymphoma and multiple myeloma patients underwent autologous hematopoietic stem cell transplantation.淋巴瘤和多发性骨髓瘤患者自体造血干细胞移植后，G-CSF 衍生物预防发热性中性粒细胞减少症的疗效和成本。
Hematology. 2021 Dec;26(1):950-955. doi: 10.1080/16078454.2021.2003071.
10
Pseudo-thrombocytopenia after autologous stem cell transplantation.自体干细胞移植后的假性血小板减少症。
Blood Coagul Fibrinolysis. 2019 Mar;30(2):66-67. doi: 10.1097/MBC.0000000000000792.
引用本文的文献
1
Balancing Benefits and Risks: A Literature Review on Hypersensitivity Reactions to Human G-CSF (Granulocyte Colony-Stimulating Factor).平衡获益与风险：人粒细胞集落刺激因子（G-CSF）过敏反应的文献综述
Int J Mol Sci. 2024 Apr 28;25(9):4807. doi: 10.3390/ijms25094807.
本文引用的文献
1
Severe thrombocytopenia related to filgrastim mobilization in a healthy donor.健康供者中与非格司亭动员相关的严重血小板减少症。
Transfus Apher Sci. 2018 Dec;57(6):777-778. doi: 10.1016/j.transci.2018.10.002. Epub 2018 Oct 6.
2
Drug-induced thrombocytopenia during G-CSF therapy in a patient with chronic neutropenia.慢性中性粒细胞减少症患者在粒细胞集落刺激因子（G-CSF）治疗期间发生药物性血小板减少症。
Turk J Haematol. 2006 Mar 5;23(1):59-62.
3
An assessment of the pharmacokinetics, pharmacodynamics, and tolerability of GCPGC, a novel pegylated granulocyte colony-stimulating factor (G-CSF), in healthy subjects.一项关于新型聚乙二醇化粒细胞集落刺激因子（G-CSF）GCPGC在健康受试者中的药代动力学、药效学及耐受性的评估。
Invest New Drugs. 2014 Aug;32(4):636-43. doi: 10.1007/s10637-014-0068-7. Epub 2014 Jan 28.
4
Relationship between absolute neutrophil count profiles and pharmacokinetics of DA-3031, a pegylated granulocyte colony-stimulating factor (pegylated-G-CSF): a dose block-randomized, double-blind, dose-escalation study in healthy subjects.达沙替尼（DA-3031），一种聚乙二醇化粒细胞集落刺激因子（PEG-G-CSF）的药代动力学与中性粒细胞绝对计数谱之间的关系：一项在健康受试者中进行的剂量分组随机、双盲、剂量递增研究。
Clin Drug Investig. 2013 Nov;33(11):817-24. doi: 10.1007/s40261-013-0130-9.
5
Drug-induced thrombocytopenia: MIBS trumps LIBS.药物性血小板减少症：微小免疫介导性血小板减少症胜过线性免疫介导性血小板减少症。
Blood. 2012 Jun 28;119(26):6177-8. doi: 10.1182/blood-2012-04-423939.
6
Granulocyte colony stimulating factor in neonatal alloimmune neutropenia: a possible association with induced thrombocytopenia.粒细胞集落刺激因子在新生儿同种免疫性中性粒细胞减少症中的作用：与诱导性血小板减少症的可能关联。
Pediatr Blood Cancer. 2010 Jul 1;54(7):1014-6. doi: 10.1002/pbc.22315.
7
Drug-induced immune thrombocytopenia: pathogenesis, diagnosis, and management.药物性免疫性血小板减少症：发病机制、诊断与管理
J Thromb Haemost. 2009 Jun;7(6):911-8. doi: 10.1111/j.1538-7836.2009.03360.x. Epub 2009 Apr 2.
8
G-CSF-induced thrombocytopenia in a healthy donor.健康供体中粒细胞集落刺激因子诱导的血小板减少症。
Bone Marrow Transplant. 2009 Feb;43(3):263-4. doi: 10.1038/bmt.2008.310. Epub 2008 Sep 29.
9
Follow-up of healthy donors receiving granulocyte colony-stimulating factor for peripheral blood progenitor cell mobilization and collection. Results of the Spanish Donor Registry.接受粒细胞集落刺激因子用于外周血祖细胞动员和采集的健康供者随访。西班牙供者登记处的结果
Haematologica. 2008 May;93(5):735-40. doi: 10.3324/haematol.12285. Epub 2008 Apr 2.
10
Profound thrombocytopenia related to G-CSF.与粒细胞集落刺激因子相关的严重血小板减少症。
Am J Hematol. 2007 Mar;82(3):229-30. doi: 10.1002/ajh.20787.
Zotero 插件